And anti-mycobacterial drug that inhibits mycobacterial ATP synthetase and depletes cellular energy stores.

Differs from other anti-mycobacterial drugs and therefore it has the capacity to retain activity against some M tuberculosis isolates resistant to other drugs.

Bedaquiline-pretomanid-linezolid  regimen has a 90% efficacy against highly drug-resistant tuberculosis.

Leave a Reply

Your email address will not be published. Required fields are marked *